392 related articles for article (PubMed ID: 11689051)
21. RhoA is activated during respiratory syncytial virus infection.
Gower TL; Peeples ME; Collins PL; Graham BS
Virology; 2001 May; 283(2):188-96. PubMed ID: 11336544
[TBL] [Abstract][Full Text] [Related]
22. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
Kahn JS; Schnell MJ; Buonocore L; Rose JK
Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
[TBL] [Abstract][Full Text] [Related]
23. Expression and characterisation of the ovine respiratory syncytial virus (ORSV) G protein for use as a diagnostic reagent.
Ghildyal R; Chapman A; Peroulis I; Mills J; Meanger J
Vet Res; 1999; 30(5):475-82. PubMed ID: 10543382
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
25. Two novel single amino acid syncytial mutations in the carboxy terminus of glycoprotein B of herpes simplex virus type 1 confer a unique pathogenic phenotype.
Engel JP; Boyer EP; Goodman JL
Virology; 1993 Jan; 192(1):112-20. PubMed ID: 8390747
[TBL] [Abstract][Full Text] [Related]
26. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
Zhang W; Tripp RA
J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
[TBL] [Abstract][Full Text] [Related]
27. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.
Bukreyev A; Yang L; Fricke J; Cheng L; Ward JM; Murphy BR; Collins PL
J Virol; 2008 Dec; 82(24):12191-204. PubMed ID: 18842713
[TBL] [Abstract][Full Text] [Related]
28. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
Pertel PE; Spear PG
Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
[TBL] [Abstract][Full Text] [Related]
29. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.
Skiadopoulos MH; Surman SR; Durbin AP; Collins PL; Murphy BR
Virology; 2000 Jun; 272(1):225-34. PubMed ID: 10873765
[TBL] [Abstract][Full Text] [Related]
30. [Primary respiratory syncytial virus infection in mice].
Zou Y; Huang H; Xu J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):484-6. PubMed ID: 11718040
[TBL] [Abstract][Full Text] [Related]
31. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.
Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF
J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931
[TBL] [Abstract][Full Text] [Related]
32. [In vitro inhibitory mechanism of respiratory syncytial virus with solution prescription of zhidanhuayu].
Liu YH; Hou AC; Zhao GC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):486-7. PubMed ID: 19544654
[TBL] [Abstract][Full Text] [Related]
33. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
34. YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.
Sudo K; Miyazaki Y; Kojima N; Kobayashi M; Suzuki H; Shintani M; Shimizu Y
Antiviral Res; 2005 Feb; 65(2):125-31. PubMed ID: 15708639
[TBL] [Abstract][Full Text] [Related]
35. Nucleotide sequence analysis of the ovine respiratory syncytial virus G glycoprotein gene.
Alansari H; Potgieter LN
Virology; 1993 Oct; 196(2):873-7. PubMed ID: 8372453
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes.
Hancock GE; Tebbey PW; Scheuer CA; Pryharski KS; Heers KM; LaPierre NA
J Med Virol; 2003 Jun; 70(2):301-8. PubMed ID: 12696122
[TBL] [Abstract][Full Text] [Related]
37. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR; Graham BS
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
[TBL] [Abstract][Full Text] [Related]
38. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
Huang Y; Cyr SL; Burt DS; Anderson R
J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
[TBL] [Abstract][Full Text] [Related]
39. Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity.
Maher CF; Hussell T; Blair E; Ring CJ; Openshaw PJ
Microbes Infect; 2004 Oct; 6(12):1049-55. PubMed ID: 15380773
[TBL] [Abstract][Full Text] [Related]
40. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro.
Franke-Ullmann G; Pförtner C; Walter P; Steinmüller C; Lohmann-Matthes ML; Kobzik L; Freihorst J
J Immunol; 1995 Jan; 154(1):268-80. PubMed ID: 7995946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
